Skip To Main Content
Ayisha Sharma on Muck Rack

Ayisha Sharma

Verified
London
As seen in: Endpoints News, MSN UK, The Guardian, Yahoo Canada, AOL UK, Her Campus, NewsBreak, Citeline, Clinical Trials Arena, In Vivo, Scrip and
Reporter @endpointsnews

Get in touch with Ayisha

Contact Ayisha, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

BridgeBio Oncology slides as it tightens the scope of its KRAS program

|
By Ayisha Sharma Verified
| Endpoints News Verified
September 10, 2026 07:09 AM EDT BridgeBio Oncology slides as it tightens the scope of its KRAS program BridgeBio Oncology Therapeutics’ share price $BBOT plummeted by about 24% at market close Wednesday on the back of plans that it is scaling back its … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?

Sanofi spells out asthma data, AstraZeneca details COPD win at #ERS26

|
By Ayisha Sharma Verified, Elizabeth Cairns Verified
| Endpoints News Verified
European Respiratory Society annual meeting in Barcelona. (Credit: ERS on Facebook) Sanofi spells out asthma data, AstraZeneca details COPD win at #ERS26 During this year’s European Respiratory Society (ERS) annual meeting in Barcelona, companies such as Sanofi and AstraZeneca lifted the curtain on detailed results from trials … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?

Roivant reports Phase 2 win for lung disease drug that it got from Bayer

|
By Ayisha Sharma Verified
| Endpoints News Verified
September 8, 2026 06:00 AM EDT Roivant reports Phase 2 win for lung disease drug that it got from Bayer Roivant Sciences said Tuesday its inhaled drug candidate has passed a mid-stage test in interstitial lung disease, surpassing Wall Street’s benchmarks for success. Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?
See all 1,334 licensed articles (1,339 Total)